FDA warned Sperm Bank, Inc. dba Fertility Center of California over donor semen released without required infectious-disease testing and screening.
What happened
FDA inspected the firm from June 7, 2024 and June 12, 2024. FDA found repeat anonymous semen donors were not tested for West Nile Virus with a licensed nucleic acid test at the first donation in the June 1–October 31 period, donor screening was incomplete, and test specimens were not collected at the time of recovery or within seven days. The letter also says the firm's procedures did not require WNV NAT and that its response to the inspection observations was inadequate.
What FDA found
Repeat anonymous semen donors were not tested for West Nile Virus with a licensed nucleic acid test at the first donation recovered during June 1 through October 31.
21 CFR 1271.85(a)Semen from repeat donors was released from quarantine without a complete donor screening procedure within the previous six months.
21 CFR 1271.75Donor specimens for communicable disease testing were not collected at recovery or within seven days before or after recovery.
21 CFR 1271.80(b)The firm's procedures did not require WNV NAT as an infectious-disease test.
21 CFR 1271.47(a)
What FDA wants
FDA asks the firm to respond in writing within 15 working days with specific corrective actions, documentation, and steps to prevent recurrence, and to keep affected HCT/Ps in quarantine unless FDA grants an exemption or alternative.
Who should pay attention
- fertility clinics that use donor semen
- sperm banks and tissue establishments
- recipients of donor sperm and their clinicians
This is a summary. Read the original letter on fda.gov.